Literature DB >> 25635587

Autosomal dominant polycystic kidney disease in children.

Melissa A Cadnapaphornchai1.   

Abstract

PURPOSE OF REVIEW: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal disease, affecting one in 500 individuals. The cardinal manifestation of ADPKD is progressive cystic dilatation of renal tubules with kidney enlargement and progression to end-stage renal disease in approximately half of cases by 60 years of age. Although previously considered a condition of adults, it is clear that children and young adults are subject to the complications of ADPKD. RECENT
FINDINGS: It has been increasingly recognized that interventions early in life are necessary in order to confer the best long-term outcome in this common condition. Therefore, it is imperative for pediatricians to recognize the manifestations and complications of this disease. Until recently ADPKD management focused on general principles of chronic kidney disease. However, several recent clinical trials in children and adults with ADPKD have focused on disease-specific therapies.
SUMMARY: This review will highlight the clinical manifestations, diagnosis, and appropriate management of ADPKD in childhood and will review recent relevant clinical trials in children and adults with this condition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25635587      PMCID: PMC4428335          DOI: 10.1097/MOP.0000000000000195

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  89 in total

Review 1.  Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Yannick Le Meur; Jian-Min Chen; Claude Férec
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

2.  Increased water intake decreases progression of polycystic kidney disease in the PCK rat.

Authors:  Shizuko Nagao; Kazuhiro Nishii; Makoto Katsuyama; Hiroki Kurahashi; Tohru Marunouchi; Hisahide Takahashi; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

3.  Dietary Approaches to Stop Hypertension (DASH) eating pattern and risk of elevated blood pressure in adolescent girls.

Authors:  Lynn L Moore; M Loring Bradlee; Martha R Singer; M Mustafa Qureshi; Justin R Buendia; Stephen R Daniels
Journal:  Br J Nutr       Date:  2012-01-16       Impact factor: 3.718

4.  Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.

Authors:  Iram Zafar; Kameswaran Ravichandran; Franck A Belibi; R Brian Doctor; Charles L Edelstein
Journal:  Kidney Int       Date:  2010-08-04       Impact factor: 10.612

5.  Improvement of coronary flow velocity reserve with telmisartan in patients with autosomal-dominant polycystic kidney disease.

Authors:  Sabahat Alisir; Kultigin Turkmen; Nilufer Alpay; Ali Elitok; Huseyin Oflaz; Bora Uslu; Arif Cimen; Erdem Kasikcioglu; Fatih Tufan; Tevfik Ecder
Journal:  South Med J       Date:  2010-05       Impact factor: 0.954

Review 6.  Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 10.121

7.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

8.  Unified criteria for ultrasonographic diagnosis of ADPKD.

Authors:  York Pei; James Obaji; Annie Dupuis; Andrew D Paterson; Riccardo Magistroni; Elizabeth Dicks; Patrick Parfrey; Benvon Cramer; Eliecer Coto; Roser Torra; Jose L San Millan; Robert Gibson; Martijn Breuning; Dorien Peters; David Ravine
Journal:  J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 10.121

9.  Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.

Authors:  Sandro Rossetti; Mark B Consugar; Arlene B Chapman; Vicente E Torres; Lisa M Guay-Woodford; Jared J Grantham; William M Bennett; Catherine M Meyers; Denise L Walker; Kyongtae Bae; Qin Jean Zhang; Paul A Thompson; J Philip Miller; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 10.121

10.  Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease.

Authors:  Filip Fencl; Jan Janda; Kveta Bláhová; Zdenek Hríbal; Jitka Stekrová; Alena Puchmajerová; Tomás Seeman
Journal:  Pediatr Nephrol       Date:  2009-02-05       Impact factor: 3.714

View more
  10 in total

1.  Turner syndrome and autosomal dominant polycystic kidney disease.

Authors:  Rachel Styer; Matthew Stephen; Faris Hashim; Krista Birkemeier
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-11-16

2.  Prevalence of cardiac valvar abnormalities in children and young people with autosomal dominant polycystic kidney disease.

Authors:  Alexandra Savis; John M Simpson; Saleha Kabir; Kelly Peacock; Hayley Beardsley; Manish D Sinha
Journal:  Pediatr Nephrol       Date:  2022-06-28       Impact factor: 3.714

3.  Long-Term Outcomes in Patients with Very-Early Onset Autosomal Dominant Polycystic Kidney Disease.

Authors:  Kristen L Nowak; Melissa A Cadnapaphornchai; Michel B Chonchol; Robert W Schrier; Berenice Gitomer
Journal:  Am J Nephrol       Date:  2016-08-23       Impact factor: 3.754

4.  Early cardiovascular manifestations in children and adolescents with autosomal dominant polycystic kidney disease: a single center study.

Authors:  Vasiliki Karava; Cherine Benzouid; Julien Hogan; Claire Dossier; André Pierre Denjean; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-05-17       Impact factor: 3.714

5.  Generation of heterozygous PKD1 mutant pigs exhibiting early-onset renal cyst formation.

Authors:  Masahito Watanabe; Kazuhiro Umeyama; Kazuaki Nakano; Hitomi Matsunari; Toru Fukuda; Kei Matsumoto; Susumu Tajiri; Shuichiro Yamanaka; Koki Hasegawa; Kazutoshi Okamoto; Ayuko Uchikura; Shuko Takayanagi; Masaki Nagaya; Takashi Yokoo; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  Lab Invest       Date:  2022-01-03       Impact factor: 5.502

6.  Central blood pressure and measures of early vascular disease in children with ADPKD.

Authors:  Matko Marlais; Sreedevi Rajalingam; Haotian Gu; Alexandra Savis; Manish D Sinha; Paul Jd Winyard
Journal:  Pediatr Nephrol       Date:  2019-06-26       Impact factor: 3.714

7.  Ppia is the most stable housekeeping gene for qRT-PCR normalization in kidneys of three Pkd1-deficient mouse models.

Authors:  Juan J Muñoz; Ana C Anauate; Luiz F Onuchic; Ita P Heilberg; Andressa G Amaral; Frederico M Ferreira; Elieser H Watanabe; Renata Meca; Milene S Ormanji; Mirian A Boim
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

Review 8.  Translational research approaches to study pediatric polycystic kidney disease.

Authors:  Max Christoph Liebau; Djalila Mekahli
Journal:  Mol Cell Pediatr       Date:  2021-12-09

9.  Bilateral primary renal diffuse large B-cell lymphoma: a rare presentation of paediatric renal disease mimicking juvenile nephronophthisis.

Authors:  Gordon Bruce; Shahzya Chaudhury; Ben Reynolds
Journal:  BMJ Case Rep       Date:  2020-07-16

10.  Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.

Authors:  Franz Schaefer; Djalila Mekahli; Francesco Emma; Rodney D Gilbert; Detlef Bockenhauer; Melissa A Cadnapaphornchai; Lily Shi; Ann Dandurand; Kimberly Sikes; Susan E Shoaf
Journal:  Eur J Pediatr       Date:  2019-05-03       Impact factor: 3.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.